Y Intercept (Hong Kong) LTD Veracyte, Inc. Transaction History

Y Intercept (Hong Kong) LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$19.72 - $28.68 $177,065 - $257,517	-8,979 Reduced 30.76%	20,207 $555,000
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $275,150 - $368,674	12,322 Added 73.07%	29,186 $651,000
Q2 2023 Aug 14, 2023	SELL	$20.96 - $26.99 $75,372 - $97,056	-3,596 Reduced 17.58%	16,864 $429,000
Q1 2023 May 09, 2023	SELL	$20.58 - $27.89 $334,651 - $453,519	-16,261 Reduced 44.28%	20,460 $456,000
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $562,198 - $1.1 Million	36,721 New	36,721 $871,000
Q2 2021 Aug 12, 2021	SELL	$32.94 - $56.62 $182,026 - $312,882	-5,526 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$44.47 - $81.38 $41,935 - $76,741	943 Added 20.58%	5,526 $273,000
Q4 2020 Feb 05, 2021	BUY	$32.49 - $61.88 $148,901 - $283,596	4,583 New	4,583 $234,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.